Navigation Links
Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351
Date:9/4/2008

351 Phase 2 program."

About Acute Myeloid Leukemia (AML)

The National Cancer Institute defines AML as a quickly progressing disease in which too many immature white blood cells (not lymphocytes) are found in the blood and bone marrow. In 2008, the American Cancer Society's Cancer Facts and Figures estimates that there will be 13,290 new cases of AML and 8,820 deaths caused by AML.

About Celator

Celator Pharmaceuticals, Inc., with locations in Princeton, NJ, and Vancouver, BC, is a privately held pharmaceutical company developing new and more effective therapies to treat cancer. CombiPlex(R), the company's drug ratio technology platform, represents a revolutionary new approach to the development of combination therapies based on identifying a fixed, synergistic ratio of the drugs pre-clinically, incorporating that ratio in a drug delivery vehicle and maintaining the ratio in patients. The company pipeline includes: CPX-1 (a liposomal formulation of irinotecan:floxuridine), currently in a Phase 2 trial in patients with colorectal cancer; CPX-351 (a liposomal formulation of cytarabine:daunorubicin), currently in a Phase 1 trial in patients with advanced leukemia; CPX 571 (a liposomal formulation of irinotecan:cisplatin), a preclinical stage compound; and multiple research programs. Based on the applications of CombiPlex, Celator is positioned to advance a broad pipeline of combination therapies involving both previously approved and novel drug agents. For more information, please visit the company's website at http://www.celatorpharma.com.


'/>"/>
SOURCE Celator Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
2. Celator(R) Pharmaceuticals Announces Positive Phase 2 Results for CPX-1 in Treatment of Colorectal Cancer
3. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
4. Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients
5. Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients
6. Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials
7. Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD)
8. Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies
9. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
10. Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000
11. Addrenex Pharmaceuticals New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Dec. 16 Frost & Sullivan,s ... looks forward to speaking at the 2010 ... place on January 9, 2010 in Las ... emerging market of consumer-based digital health and ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ,, Bujnoch focuses ...
(Date:12/16/2009)... Inc., an inhalation drug delivery company, today announced that ... A financing round, exceeding the targeted total raise amount ... the Series A round will be utilized to continue ... now have the runway and resources to effectively demonstrate ... Rob Neville, CEO of Savara. ,, The company ...
(Date:12/16/2009)... Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), today ... primate study of its novel, once-a-day, oral antibiotic ... tularemia. A 14-day course of Restanza achieved a ... All of the ten animals in the study ... to a human dose of 300 mg) within ...
Breaking Medicine Technology:Frost & Sullivan to Speak at 2010 International Consumer Electronics Digital Health Summit 2Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent 2Advanced Life Sciences' Restanza Shows 100% Survival in Tularemia Pivotal Animal Study 2Advanced Life Sciences' Restanza Shows 100% Survival in Tularemia Pivotal Animal Study 3Advanced Life Sciences' Restanza Shows 100% Survival in Tularemia Pivotal Animal Study 4New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 6657 1New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 6657 2New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 6657 3New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 6657 4New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 6657 5New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 6657 6New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 6657 7Serious Pregnancy Complication Detected With MRI 62389 1Serious Pregnancy Complication Detected With MRI 62389 2Employers Plan to Increase Use of Self Service Decision Making Technology For Open Enrollment Watson Wyatt Survey Finds 62384 1Employers Plan to Increase Use of Self Service Decision Making Technology For Open Enrollment Watson Wyatt Survey Finds 62384 2Employers Plan to Increase Use of Self Service Decision Making Technology For Open Enrollment Watson Wyatt Survey Finds 62384 3
... demonstrating the essential,role of humane animal research ... June 19 The Foundation for,Biomedical Research ... 7th Annual,Michael E. DeBakey Journalism Awards. The ... 2008 Congressional Gold Medal recipient Dr. Michael ...
... 19 Accelerated Community Oncology,Research Network(TM) (ACORN) ... network; Guardian EDC(TM); PACE(TM) PRO System; and,proprietary ... DIA Meeting,June 22-26, in Boston, MA., ... March, 2008 the company announced its Contract ...
Other Medicine Technology:The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards 2ACORN Showcases Oncology CRO, EDC, PRO and Data Warehouse at 44th Annual DIA Meeting 2
(Date:12/16/2009)... , , TUESDAY, Dec. 15 (HealthDay News) -- If that ... on your life that you just can,t wait to have ... you might want to wait at least six months before ... be even better. , The study found that when ... chances of the baby dying, being born prematurely, having birth ...
(Date:12/16/2009)... Inc. ("TSO3") (TSX: TOS) and 3M (MMM) today ... 3M to be the exclusive supplier and distributor ... TSO3, an innovator in low temperature sterilization technology ... use of ozone, will include new cycles to ... channel. This agreement, combined with recent improvements to ...
(Date:12/16/2009)... development of products that help survivors of stroke and other ... publication of an interview with the inventors of their brand ... Therapy and Rehab Medicine, vol. 20, issue 20, page 26, ... ... (PRWEB) December 16, 2009 -- In the publication, ...
(Date:12/16/2009)... another product or thing for your loved ones this holiday season, ... services like housekeeping, errand running, child care, and pet care through ... ... 2009 -- Residents of the Denver and Boulder metro areas have ... friends and loved ones by using Delegate Source,s " Give a ...
(Date:12/15/2009)... a Life Sciences company engaged in the research, development and commercialization of technologies that target ... the Company had proposed at the Annual General Meeting of Shareholders held on December 14, ... Votes ... Non-, Matter ... For Against ...
Breaking Medicine News(10 mins):Health News:For Babies' Sake, Pregnancy Spacing Matters 2Health News:For Babies' Sake, Pregnancy Spacing Matters 3Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 2Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 3Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 4Health News:New Tailwind Device Improves Arm Function in Stroke Survivors with Paralysis 2Health News:Give the Gift of Service This Holiday Season with Delegate Source 2Health News:Give the Gift of Service This Holiday Season with Delegate Source 3Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 2Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 3
... Against More Diseases than Ever ... ... immunization,recommendations for childhood influenza and adolescent meningococcal,vaccinations are included in the ... for Disease Control and,Prevention (CDC), the American Academy of Pediatrics (AAP), ...
... $450K to Prop ... 93, ... be compelled to buy health insurance under the,Massachusetts mandatory purchase law, according to ... plan pending in,California., As reported in the Boston Globe, Jonathan Gruber, a ...
... 11 International Dairy,Foods Association (IDFA) President and CEO ... Food Safety Authority (EFSA),released its draft report on animal ... United States was a full,year ago with respect to ... animal cloning. Today,s draft scientific report is,simply the first ...
... Comprehensive health care reform is too important, the stakes for, ... ... changes., SACRAMENTO, Calif., Jan. 11 As ... reform,proposal hammered out by Governor Arnold Schwarzenegger and Assembly,Speaker Fabian Nunez, the ...
... officials announced,today that a new generic prescription drug program ... and drugstores., The program offers a 30-day supply ... prescription. The medicines on the list include antibiotics and ... and digestive issues., There are no forms to ...
... how the two sexes evolved , FRIDAY, Jan. 11 (HealthDay News) ... contain clues to gender development in humans. , Duke University researchers ... Nature . , In research with Phycomyces blakesleeanus , ... mating. They named these versions sexM (sex minus) and sexP (sex ...
Other Medicine News:Health News:Health Groups Release 2008 Immunization Schedules 2Health News:MA Proponent of Health Insurance Mandate Says 'Mean' Penalties Needed to Force People to Buy Insurance 2Health News:IDFA: Dairy Processors Urge Further Review of Cloning 2Health News:Insurance Agents Call for State Senate to Improve California's Health Care Reform Compromise 2Health News:Hy-Vee Unveils New Generic Drug Program 2Health News:Fungus Sheds Light on Development of Human Genders 2
... The autoLog™ Autotransfusion System processes blood ... produce washed red blood cells for ... later time. This is achieved with ... An innovative bowl design, coupled with ...
The Wixson Hip Positioner is used for stable positioning of a patient during total hip and revision surgery. It is designed to be placed on top of the operating table....
Stryker Instruments InterPulse System advances the ease and performance of battery powered irrigation for Orthopaedics, Trauma, and Wound Care....
... VersaNail System is a complete system of ... use with TTC fusion surgery. The system ... and integrates clinical research and engineering with ... every patient is different, and because the ...
Medicine Products: